Skip to content
Recall Observatory FDA recall evidence

Drug product

DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for Hospira Inc., Lake Forest, IL 60045 USA. NDC 0409-2344-02

D-1540-2014

January 10, 2014

Class I

Product summary

Firm
Hospira Inc.
Event
Event 67354
Status
Terminated
Classification
Class I
Quantity
123,900 vials
Official record key
drug-enforcement:D-1540-2014

Official wording

Reason: Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.

Code information: Lot # 27-352-DK; Exp 03/15

Distribution pattern: Nationwide and Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter